Oussama Abla

8.9k total citations · 1 hit paper
93 papers, 1.7k citations indexed

About

Oussama Abla is a scholar working on Physiology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Oussama Abla has authored 93 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 23 papers in Pathology and Forensic Medicine and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Oussama Abla's work include Histiocytic Disorders and Treatments (27 papers), Acute Lymphoblastic Leukemia research (22 papers) and Lymphoma Diagnosis and Treatment (20 papers). Oussama Abla is often cited by papers focused on Histiocytic Disorders and Treatments (27 papers), Acute Lymphoblastic Leukemia research (22 papers) and Lymphoma Diagnosis and Treatment (20 papers). Oussama Abla collaborates with scholars based in Canada, United States and Netherlands. Oussama Abla's co-authors include Sheila Weitzman, Julien Haroche, R. Maarten Egeler, Carl E. Allen, James A. Whitlock, Lillian Sung, Eli L. Diamond, Marta Wilejto, Kenneth L. McClain and Johann Hitzler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Oussama Abla

85 papers receiving 1.7k citations

Hit Papers

Consensus recommendations for the diagnosis and clinical ... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oussama Abla Canada 25 816 524 481 391 273 93 1.7k
Kevin Windebank United Kingdom 17 586 0.7× 335 0.6× 218 0.5× 231 0.6× 353 1.3× 54 1.2k
Christelle Sordet France 26 462 0.6× 130 0.2× 607 1.3× 142 0.4× 357 1.3× 85 2.3k
Carlo Bellini Italy 22 319 0.4× 306 0.6× 126 0.3× 654 1.7× 1.0k 3.7× 107 1.9k
T Généreau France 20 945 1.2× 477 0.9× 237 0.5× 131 0.3× 541 2.0× 63 2.1k
H Rousset France 22 287 0.4× 200 0.4× 576 1.2× 104 0.3× 290 1.1× 119 1.8k
M M Reid United Kingdom 24 149 0.2× 192 0.4× 106 0.2× 202 0.5× 150 0.5× 80 1.5k
Biljana Horn United States 29 123 0.2× 100 0.2× 123 0.3× 305 0.8× 239 0.9× 84 2.0k
Fernanda Falcini Italy 28 174 0.2× 101 0.2× 437 0.9× 139 0.4× 580 2.1× 62 2.4k
Mark D. P. Davis United States 29 216 0.3× 88 0.2× 495 1.0× 132 0.3× 323 1.2× 85 2.3k
Amy J. Nopper United States 17 151 0.2× 256 0.5× 863 1.8× 558 1.4× 2.1k 7.8× 34 2.7k

Countries citing papers authored by Oussama Abla

Since Specialization
Citations

This map shows the geographic impact of Oussama Abla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oussama Abla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oussama Abla more than expected).

Fields of papers citing papers by Oussama Abla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oussama Abla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oussama Abla. The network helps show where Oussama Abla may publish in the future.

Co-authorship network of co-authors of Oussama Abla

This figure shows the co-authorship network connecting the top 25 collaborators of Oussama Abla. A scholar is included among the top collaborators of Oussama Abla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oussama Abla. Oussama Abla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Jinjun, R Mariani, Metin Özdemirli, et al.. (2024). Clinical and pathological features of pediatric peripheral T-cell lymphoma after solid organ transplantation. PubMed. 1(4). 100039–100039.
2.
Fahy, Aodhnait S., et al.. (2024). Outcomes for pediatric acute lymphoblastic leukemia patients with intestinal perforation. Pediatric Blood & Cancer. 71(4). e30899–e30899.
3.
Abla, Oussama, Rhonda E. Ries, Timothy J. Triche, et al.. (2024). Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia. Blood Advances. 8(8). 2005–2017. 1 indexed citations
4.
Abla, Oussama, et al.. (2023). Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors. Pediatric Drugs. 25(4). 399–409. 6 indexed citations
5.
Reiner, Anne S., et al.. (2022). Rosai–Dorfman–Destombes disease of the nervous system: a systematic literature review. Orphanet Journal of Rare Diseases. 17(1). 92–92. 10 indexed citations
6.
Desjardins, Léandra, Kelly Hancock, Péter Szatmári, et al.. (2021). Protocol for mapping psychosocial screening to resources in pediatric oncology: a pilot randomized controlled trial. Pilot and Feasibility Studies. 7(1). 143–143. 7 indexed citations
8.
Tandon, Sneha, Mary Shago, Scott Davidson, et al.. (2020). First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia. Cancer Genetics. 248-249. 31–33. 3 indexed citations
9.
Pole, Jason D., et al.. (2019). Impact of Videotaped Information on the Experience of Parents of Children with Acute Lymphoblastic Leukemia. Journal of Cancer Education. 35(3). 479–484. 1 indexed citations
10.
Abla, Oussama, Raul C. Ribeiro, Anna Maria Testi, et al.. (2017). Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Annals of Hematology. 96(9). 1449–1456. 27 indexed citations
11.
12.
Vaiselbuh, Sarah R., Yenan T. Bryceson, Carl E. Allen, James A. Whitlock, & Oussama Abla. (2014). Updates on histiocytic disorders. Pediatric Blood & Cancer. 61(7). 1329–1335. 65 indexed citations
13.
Klaassen, Robert J., Murray Krahn, Isabelle Gaboury, et al.. (2010). Evaluating the ability to detect change of health‐related quality of life in children with Hodgkin disease. Cancer. 116(6). 1608–1614. 29 indexed citations
14.
Chong, Amy Lee, Bo‐Yee Ngan, Sheila Weitzman, & Oussama Abla. (2009). Anaplastic Large Cell Lymphoma of the Ovary in a Pediatric Patient. Journal of Pediatric Hematology/Oncology. 31(9). 702–704. 8 indexed citations
15.
Breakey, Vicky R., M. Stephen Meyn, Vicky L. Ng, et al.. (2009). Hepatitis-associated Aplastic Anemia Presenting as a Familial Bone Marrow Failure Syndrome. Journal of Pediatric Hematology/Oncology. 31(11). 884–887. 5 indexed citations
16.
Hayes, Jason, et al.. (2008). Coadministration of Propofol and Remifentanil for Lumbar Puncture in Children. Anesthesiology. 109(4). 613–618. 16 indexed citations
17.
Diezi, Manuel, et al.. (2008). Sevelamer hydrochloride: A novel treatment of hyperphosphatemia associated with tumor lysis syndrome in children. Pediatric Blood & Cancer. 51(1). 59–61. 9 indexed citations
18.
Scheinemann, Katrin, Sheila Weitzman, Johann Hitzler, John Doyle, & Oussama Abla. (2008). Isolated Central Nervous System Relapse in Childhood Acute Promyelocytic Leukemia. Journal of Pediatric Hematology/Oncology. 30(2). 160–162. 6 indexed citations
19.
Abdelhaleem, Mohamed, et al.. (2007). Childhood myeloid/natural killer precursor acute leukemia with novel chromosomal aberrations der(5)t(4;5)(q31;q31.3) and t(14;17)(q32;q23). Cancer Genetics and Cytogenetics. 178(2). 141–143. 1 indexed citations
20.
Abla, Oussama & Sheila Weitzman. (2006). Primary central nervous system lymphoma in children. Neurosurgical FOCUS. 21(5). 1–8. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026